Literature DB >> 8263916

X-ray structure of a monomeric cyclophilin A-cyclosporin A crystal complex at 2.1 A resolution.

V Mikol1, J Kallen, G Pflügl, M D Walkinshaw.   

Abstract

The crystal structure of a complex between recombinant human cyclophilin A (Cyp) and cyclosporin A (CsA) has been determined from a novel orthorhombic crystal form that contains only one monomer of complex per asymmetric unit rather than five in the previously determined tetragonal structure. The structure has been refined at 2.1 A resolution to a crystallographic R-factor of 16.7%. The conformation of Cyp is practically unchanged with respect to the tetragonal form. A certain number of previously undefined side-chains have been located in the electron density and a very detailed picture of the ordered solvent structure has been obtained. The interactions between CsA and Cyp are conserved. A network of the possibly conserved, water-mediated contacts is described. The structure of CsA in the monomeric complex is similar to that of the decameric complex, but shows a few small differences in the so-called effector domain of CsA, probably due to differences in crystal environment. The fact that this monomeric crystal form can be obtained shows that the formation of pentamer or decamer complexes is not a generally observed phenomenon and is not a prerequisite for biological activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8263916     DOI: 10.1006/jmbi.1993.1664

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  41 in total

1.  Folding of barstar C40A/C82A/P27A and catalysis of the peptidyl-prolyl cis/trans isomerization by human cytosolic cyclophilin (Cyp18).

Authors:  R Golbik; G Fischer; A R Fersht
Journal:  Protein Sci       Date:  1999-07       Impact factor: 6.725

Review 2.  Peptidyl-prolyl isomerases: a new twist to transcription.

Authors:  Peter E Shaw
Journal:  EMBO Rep       Date:  2002-06       Impact factor: 8.807

3.  Actinobacteria cyclophilins: phylogenetic relationships and description of new class- and order-specific paralogues.

Authors:  Angel Manteca; Ana I Pelaez; Rafael Zardoya; Jesus Sanchez
Journal:  J Mol Evol       Date:  2006-11-10       Impact factor: 2.395

4.  A molecular dynamics study of Cyclophilin A free and in complex with the Ala-Pro dipeptide.

Authors:  Pekka Mark; Lennart Nilsson
Journal:  Eur Biophys J       Date:  2007-01-16       Impact factor: 1.733

5.  Targeting the cyclophilin domain of Ran-binding protein 2 (Ranbp2) with novel small molecules to control the proteostasis of STAT3, hnRNPA2B1 and M-opsin.

Authors:  Kyoung-In Cho; Andrew Orry; Se Eun Park; Paulo A Ferreira
Journal:  ACS Chem Neurosci       Date:  2015-06-12       Impact factor: 4.418

6.  The 20kD protein of human [U4/U6.U5] tri-snRNPs is a novel cyclophilin that forms a complex with the U4/U6-specific 60kD and 90kD proteins.

Authors:  S Teigelkamp; T Achsel; C Mundt; S F Göthel; U Cronshagen; W S Lane; M Marahiel; R Lührmann
Journal:  RNA       Date:  1998-02       Impact factor: 4.942

7.  Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells.

Authors:  D Braaten; J Luban
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

8.  X-ray structure of a cyclophilin B/cyclosporin complex: comparison with cyclophilin A and delineation of its calcineurin-binding domain.

Authors:  V Mikol; J Kallen; M D Walkinshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  The crystal structure of PPIL1 bound to cyclosporine A suggests a binding mode for a linear epitope of the SKIP protein.

Authors:  Christian M Stegmann; Reinhard Lührmann; Markus C Wahl
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

10.  Functions of FKBP12 and mitochondrial cyclophilin active site residues in vitro and in vivo in Saccharomyces cerevisiae.

Authors:  K Dolinski; C Scholz; R S Muir; S Rospert; F X Schmid; M E Cardenas; J Heitman
Journal:  Mol Biol Cell       Date:  1997-11       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.